AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21386974
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (50 mg per day)
Trial: 7589024
Drug: Triazolam (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.125 mg or 0.25 mg)
Trial: 2260872
Drug: High-dose dl-Leucovorin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dl-Leucovorin (500 mg/m2) and 5-FU (600 mg/m2)
Trial: 6768078
Drug: Heroin self-administration
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin self-administration with naltrexone placebo
Trial: 16140230
Drug: Supervised home
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supervised home exercise programme (twice-weekly for 6 weeks)
Trial: 12096962
Drug: 0.005% latanoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.005% latanoprost and 0.5% timolol combination therapy
Trial: 12096962
Drug: 0.005% latanoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.005% latanoprost monotherapy
Trial: 12096962
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol monotherapy
Trial: 7798505
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and dipyridamole (25 mg of aspirin and 200 mg of dipyridamole twice daily)
Trial: 1902404
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and dipyridamole
Trial: 2346545
Drug: Econazole 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Econazole 1% spray
Trial: 3583491
Drug: Fenticonazole 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenticonazole 2% cream
Trial: 2346545
Drug: Fenticonazole spray
RxNorm normalized name: fenticonazole
DrugBank: Fenticonazole (DB13434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenticonazole spray
Trial: 393378
Drug: PACe (Cis-dichlorodiammineplatinum(II)
RxNorm normalized name: CIS-DIAMMINEDICHLOROPLATINUM II
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PACe (Cis-dichlorodiammineplatinum(II) 80 mg/m2 iv Day 1, Adriamycin 40 mg/m2 iv Day 1, cyclophosphamide 200 mg/m2 orally Days 2-5)
Trial: 29400014
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment with oral MPA (400-600 mg/day)
Trial: 29400014
Drug: Repeated treatment
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated treatment with oral MPA (400-600 mg/day)
Trial: 1960301
Drug: Aspirin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (75 mg/day)
Trial: 23555538
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg/day)
Trial: 27418597
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus Aspirin
Trial: 9431857
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy (one or a combination of two first-line antihypertensive drugs) for 6 months
Trial: 9116923
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg)
Trial: 8099804
Drug: Placebo (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (50 mg vitamin C)
Trial: 30361237
Drug: Probenecid (PROB)
RxNorm normalized name: Probenecid
DrugBank: Probenecid (DB01032)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Probenecid (PROB) 1000 mg orally
Trial: 30361237
Drug: Probenecid (PROB)
RxNorm normalized name: Probenecid
DrugBank: Probenecid (DB01032)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Probenecid (PROB) 1000 mg orally with Furosemide (FSM) 40 mg orally
Trial: 30361237
Drug: Furosemide (FSM)
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide (FSM) 40 mg orally
Trial: 28814399
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g soybean oil
Trial: 28814399
Drug: 32 g
RxNorm normalized name: PEG-32 Glyceryl Laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 g soybean oil
Trial: 11744466
Drug: Alfuzosin 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 15 mg OD
Trial: 10770448
Drug: Sertraline (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50-200 mg/day)
Trial: 8626364
Drug: Nefazodone and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefazodone and Sertraline
Trial: 29878382
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg ixekizumab every 2 weeks
Trial: 29878382
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg ixekizumab every 4 weeks
Trial: 20634300
Drug: Corticosteroids (methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (methylprednisolone pulse for 3 days in months 1, 3, and 5, oral prednisone 0.5 mg/kg every other day, azathioprine 1.5 mg/kg per day for 6 months)
Trial: 1416418
Drug: ANP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ANP infusion at 3.0 pmol/kg/min
Trial: 3933317
Drug: Buccal nitroglycerin
RxNorm normalized name: nitroglycerin Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal nitroglycerin (GTN) 3 mg administered 3 times daily
Trial: 3933317
Drug: Oral isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral isosorbide dinitrate (ISDN) 30 mg administered 4 times daily
Trial: 28940681
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education for caregivers and provision of ultrasonic cleaning devices
Trial: 15126742
Drug: Otosporin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otosporin (1 mL)
Trial: 15126742
Drug: 1% aqueous
RxNorm normalized name: Zotane-HC 0.1%-1%-1% Aqueous Otic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% aqueous NCT solution (1 mL)
Trial: 3963319
Drug: Oral flunitrazepam
RxNorm normalized name: flunitrazepam
DrugBank: Flunitrazepam (DB01544)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral flunitrazepam
Trial: 3963319
Drug: Oral pentobarbital
RxNorm normalized name: Pentobarbital
DrugBank: Pentobarbital (DB00312)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pentobarbital
Trial: 3963318
Drug: Oral NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral NaCl solution
Trial: 3963319
Drug: Intramuscular pethidine
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular pethidine
Trial: 3963319
Drug: Intramuscular droperidol/fentanyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular droperidol/fentanyl
Trial: 3963318
Drug: Intramuscular NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular NaCl solution
Trial: 25914349
Drug: 40 intravesical
RxNorm normalized name: valrubicin
DrugBank: Valrubicin (DB00385)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 40 intravesical BoNT‐A injections (100 U in 10 mL)
Trial: 22085338
Drug: High-dosage bevacizumab
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dosage bevacizumab (15 mg/kg)
Trial: 22085338
Drug: Low-dosage bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Low-dosage bevacizumab (7.5 mg/kg)
Trial: 23683134
Drug: Febuxostat 40
RxNorm normalized name: febuxostat 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat 40 mg
Trial: 19286847
Drug: Febuxostat 80
RxNorm normalized name: febuxostat 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat 80 mg
Trial: 20370912
Drug: Allopurinol 300
RxNorm normalized name: allopurinol 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 300 mg (200 mg in moderate renal impairment)
Trial: 19155521
Drug: HPV-16 L1
RxNorm normalized name: HPV 16 E7/HSP65 vaccine
DrugBank: Verpasep caltespen (DB04959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV-16 L1 VLP vaccine
Trial: 10616257
Drug: Individual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual administration of HGSHS:A, TAS, DES, PCI
Trial: 10616257
Drug: Group administration
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group administration of HGSHS:A, TAS, DES, PCI
Trial: 3728935
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous fluids
Trial: 25528104
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (AT) group
Trial: 16187871
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg cortisol
Trial: 19735771
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTX‐A) combined with a defined therapy program
Trial: 19735771
Drug: Therapy alone
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy alone
Trial: 19735771
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (BTX‐A and therapy alone)
Trial: 18067007
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (81 mg) with thalidomide/dexamethasone
Trial: 18067007
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin with thalidomide/dexamethasone
Trial: 18067007
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin with lenalidomide-containing regimen (clarithromycin, lenalidomide, dexamethasone)
Trial: 18067007
Drug: Dexamethasone alone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone alone (without aspirin)
Trial: 15519009
Drug: Heparin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin + routine GP IIb/IIIa inhibition
Trial: 19238088
Drug: Fluoxetine 60-80
RxNorm normalized name: fluoxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 60-80 mg/day
Trial: 28263650
Drug: Supportive-expressive (SE)
RxNorm normalized name: Selenomethionine Se-75
DrugBank: Selenomethionine Se-75 (DB09400)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-expressive (SE) psychodynamic treatment
Trial: 25212601
Drug: 3D conformal
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3D conformal radiation therapy (3D‐CRT, 70 Gy/35 fractions)
Trial: 25212601
Drug: Intensity‐modulated radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity‐modulated radiation therapy (IMRT, 76 Gy/38 fractions)
Trial: 25212601
Drug: APC for
RxNorm normalized name: Recombinant human activated protein C (rH-APC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APC for Grade 2 or 3 rectal bleeding
Trial: 12453903
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg b.i.d.)
Trial: 18390799
Drug: Metformin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1 g b.i.d.)
Trial: 21873632
Drug: Aspirin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (75 mg daily)
Trial: 9431533
Drug: 5% acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% acyclovir cream
Trial: 30672128
Drug: mirogabalin 30
RxNorm normalized name: mirogabalin
DrugBank: Mirogabalin (DB11825)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: mirogabalin 30 mg/day
Trial: 30672128
Drug: mirogabalin 15
RxNorm normalized name: mirogabalin
DrugBank: Mirogabalin (DB11825)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: mirogabalin 15 mg/day
Trial: 11991778
Drug: Daily Undulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Undulating Periodization (DUP)
Trial: 24461313
Drug: Krill oil
RxNorm normalized name: Krill oil
DrugBank: Krill oil (DB16615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill oil (0.5, 1, 2, or 4 g/day)
Trial: 22012469
Drug: 0.8% hyaluronan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8% hyaluronan gel
Trial: 11894974
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ACTH [1‐24] (0.1 microg, 0.5 microg, 1.0 microg per 1.73 m2)
Trial: 11894974
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose ACTH [1‐24] (250 microg, 60-minute HDT)
Trial: 11894974
Drug: 8-h infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-h infusion test (250 microg ACTH [1‐24] at a constant rate over 8 h)
Trial: 11894974
Drug: Insulin hypoglycaemia
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin hypoglycaemia test (IHT)
Trial: 11894974
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ACTH [1‐24] (0.1 microg, 0.5 microg, 1.0 microg)
Trial: 11894974
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose ACTH [1‐24] (HDT)
Trial: 9452545
Drug: Combination at-home
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination at-home and in-office system with a 15% carbamide peroxide at-home bleaching agent
Trial: 24470342
Drug: Trimetazidine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (20 mg three times daily)
Trial: 378729
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg three times daily)
Trial: 3141537
Drug: Aspirin (topical)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (topical)
Trial: 3141537
Drug: Indomethacin (topical)
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin (topical)
Trial: 3141537
Drug: Piroxicam (topical)
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Piroxicam (topical)
Trial: 25470086
Drug: Oral antipsychotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antipsychotic regimens
Trial: 30393935
Drug: ATRA plus
RxNorm normalized name: ATRA
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ATRA plus chemotherapy
Trial: 31455589
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive pills containing drospirenone
Trial: 27986370
Drug: Ethyl chloride
RxNorm normalized name: Ethyl Chloride
DrugBank: Ethyl chloride (DB13259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethyl chloride spray
Trial: 16634384
Drug: Ametop cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ametop cream
Trial: 8151317
Drug: Multiagent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiagent chemotherapy and cranial irradiation
Trial: 8151317
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of methotrexate and cytarabine (ara‐c)
Trial: 3047215
Drug: prednisolone 21‐phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone 21‐phosphate 30 mg (PP)
Trial: 3047215
Drug: beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beclomethasone dipropionate 1 mg (BDP)
Trial: 23426902
Drug: Extended-release carbidopa-levodopa
RxNorm normalized name: carbidopa / levodopa Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release carbidopa-levodopa (IPX066)
Trial: 23426902
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (IPX066 and IR CD-LD)
Trial: 22101764
Drug: Dexpramipexole (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexpramipexole (50, 150 or 300 mg d(‐1))
Trial: 22101764
Drug: Dexpramipexole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexpramipexole (50 mg d(‐1) or 300 mg d(‐1))
Trial: 18979718
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination perindopril-indapamide
Trial: 16988008
Drug: Ebola virus
RxNorm normalized name: Anti-Ebola virus IgG antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebola virus DNA vaccine (2 mg, 4 mg, or 8 mg)
Trial: 8147164
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion for Bishop score > 8
Trial: 25219986
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg methylprednisolone acetate injected postoperatively into the masseter muscle
Trial: 22964250
Drug: LFF571 single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LFF571 single doses (25 mg, 100 mg, 400 mg, and 1,000 mg)
Trial: 22964250
Drug: LFF571 multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LFF571 multiple doses (25 mg, 100 mg, or 200 mg every 6 h for 10 days)
Trial: 19306963
Drug: Barusiban (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barusiban (0.3, 1, 3, or 10 mg)
Trial: 19148936
Drug: No inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No inhaled nitric oxide (no iNO)
Trial: 15125004
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fuzzy merging and wall-thickening analysis
Trial: 11453312
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (0.8 mg m(‐2) day(‐1) for 1 month, then 0.4 mg m(‐2) day(‐1) for 3 months)
Trial: 8061853
Drug: Spirapril 6
RxNorm normalized name: spirapril 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 6 mg/day
Trial: 8061853
Drug: Spirapril 12
RxNorm normalized name: spirapril 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 12 mg/day
Trial: 8061853
Drug: Spirapril 24
RxNorm normalized name: spirapril 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 24 mg/day
Trial: 24006669
Drug: Acupuncture group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture group received acupuncture stimulation at various acupoints (Baihui, Neiguan, Sanyinjiao, Taichong, etc.) once daily, 5 times a week for 20 times.
Trial: 21869695
Drug: Donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 5 mg for 2 weeks
Trial: 16384626
Drug: CC haplotype
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC haplotype
Trial: 16384626
Drug: -842 CC
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: -842 CC genotype or CC haplotype
Trial: 15325930
Drug: Subclinical hyperthyroidism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subclinical hyperthyroidism (during antithyroid therapy)
Trial: 10571698
Drug: Antithyroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithyroid treatment
Trial: 15240983
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg encapsulated sumatriptan
Trial: 10987048
Drug: Medico-surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medico-surgical treatment (including nerve surgical decompression)
Trial: 10987048
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (steroids only)
Trial: 2073120
Drug: Clotrimazole troches
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole troches (10 mg each, five troches daily for 14 days)
Trial: 2073120
Drug: Fluconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (100 mg daily for 14 days)
Trial: 30226796
Drug: Extended-release carbidopa-levodopa
RxNorm normalized name: carbidopa / levodopa Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release carbidopa-levodopa (CD-LD) product
Trial: 30226796
Drug: Immediate-release carbidopa-levodopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release carbidopa-levodopa (CD-LD) product
Trial: 25169642
Drug: Escitalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (10 mg single dose)
Trial: 22896670
Drug: Statin-fenofibric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin-fenofibric acid therapy (FNA)